A5004233584- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
- SARS-CoV-2 and COVID-19 Research
- Cardiac Arrhythmias and Treatments
- Mechanical Circulatory Support Devices
- Cardiac pacing and defibrillation studies
- Aortic Disease and Treatment Approaches
- Aortic aneurysm repair treatments
- Myasthenia Gravis and Thymoma
- COVID-19 Clinical Research Studies
- Healthcare Regulation
- Thyroid Disorders and Treatments
- Cardiac Structural Anomalies and Repair
- Infective Endocarditis Diagnosis and Management
- Kawasaki Disease and Coronary Complications
- Cardiovascular Function and Risk Factors
- Pericarditis and Cardiac Tamponade
- Heart Failure Treatment and Management
Universidade Federal da Bahia
2023
Mechanical heart valves (MHV) are extremely durable, but they require permanent use of anticoagulation to prevent thromboembolic events. The only approved therapeutic options vitamin K antagonists (VKAs), such as warfarin. As a drug class, clinical management is difficult, therefore new alternatives need be evaluated. RIWA phase II/III, prospective, open-label, randomized, pilot study designed investigate oral rivaroxaban 15 mg twice daily compared with dose-adjusted warfarin for the...
Heart Failure (HF) has been identified as an important public health problem, with high morbidity and mortality, despite advances in current therapy. New strategies are demanded to reduce the number of hospitalizations deaths. Telemedicine approaches could improve management patients cardiovascular conditions. Sixty heart failure reduced ejection fraction (HFrEF) were randomized this pilot study. Weekly electronic messages sent for 1 year. The use telemedicine was effective instrument...
A 23-year-old woman was diagnosed with Graves’ disease 5 months ago decompensated thyroid function, for which she is taking thiamazole and propranolol. She developed progressive respiratory dyspnoea [New York Heart Association (NYHA) class III] frequent palpitations. On emergency admission, the patient tachypnoeic, hypotensive (77/54 mm Hg) tachycardic (120 beats per minute), an oxygen saturation of 94%. also presented cold, swollen shaky extremities, extended capillary filling time, a...
The new Coronavirus disease was first identified from an outbreak in Wuhan, China, December 2019. Patients with cardiovascular diseases or risk factors, especially those who had been diagnosed Heart Failure (HF) have expressing great concern.This population became more vulnerable when contaminated the Sars cov 2 virus [1]. Questions raised about vaccines as they were developed by research centers and pharmacy industry.